This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Teva-Valsartan (2017-05-11)

Starting date:
May 11, 2017
Posting date:
June 22, 2017
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-63728

Reason

Affected lot may contain tablets that do not meet its specification for physical description.

Depth of distribution

Pharmacies and hospitals in BC, AB, MB, ON, QC, NB, NL

Affected products

Teva-Valsartan

DIN, NPN, DIN-HIM

DIN 02356678

Dosage form

Tablet

Strength

160 mg Valsartan

Lot or serial number

35210816A

Companies

Recalling Firm
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA

Date modified: